Shareholders who lost money in shares of SelectQuote, Inc. (NYSE: SLQT) Should Contact Wolf Haldenstein Immediately

Core Viewpoint - A securities class action lawsuit has been filed against SelectQuote, Inc. for allegedly misleading investors regarding its business practices and compliance with regulations [1][2]. Allegations - SelectQuote allegedly steered Medicare beneficiaries to insurance plans that provided the highest commissions rather than those best suited for customers [7]. - The company is accused of failing to provide unbiased Medicare Advantage comparisons as claimed [7]. - SelectQuote reportedly accepted illegal kickbacks to favor certain insurers, limiting competition [7]. - The company is alleged to have been non-compliant with laws, regulations, and contracts, exposing it to regulatory and legal risks, including under the False Claims Act [7]. - Positive statements made by SelectQuote about its business and prospects were misleading and lacked a reasonable basis [7]. Impact on Investors - Following the announcement by the U.S. Department of Justice on May 1, 2025, SelectQuote's stock price fell by 19.2%, decreasing by $0.61 to close at $2.56 per share [3]. Legal Context - Investors have until October 10, 2025, to seek appointment as lead plaintiff in the case [4]. - The law firm representing the investors, Wolf Haldenstein Adler Freeman & Herz LLP, has over 125 years of experience in securities litigation [4]. Key Events - The U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging that from 2016 to 2021, the company received tens of millions of dollars in illegal kickbacks from insurers [7]. - The DOJ also alleged that SelectQuote conspired with major insurers to discriminate against less profitable beneficiaries, including those with disabilities [7]. - The DOJ concluded that SelectQuote falsely claimed to provide "unbiased coverage comparisons" while steering customers toward higher-paying plans [7].